← Leaderboards
Berthony Deslouches
University Of Pittsburgh At Pittsburgh
$3,985,460
Attributed
$3,985,460
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $653.9K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,985,460 · 2
By mechanism
R01$3,985,460 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Yohei Doi$5,766,320
- Yuanpu Peter Di$9,824,961
- Pallavi Ghosh$3,930,342
- Ghady Haidar$895,725
- Fernanda P. Silveira$4,141,926
Others in their field
Other Emerging Leaders on “Indexing”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Abraham Aizer Brody · New York University School Of Medicine$15,928,507
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Carla M Bann · Research Triangle Institute$11,018,358
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$10,241,460
- Ionut Bebu · George Washington University$9,972,097
Research focus
IndexingIn VitroDesignHydrophobicityInfectionInvestigationClinical DevelopmentColistinDoseEngineeringBacterial ResistanceAnimal ModelAntibioticsInfectious Disease TreatmentAnti-Bacterial AgentsBactericideAntimicrobialClinical ResearchAmino AcidsBiophysicsBacteriaEndotoxinsAntibiotic ResistanceIn Vivo
Grant awards (9)
Structural determinants of activity and mechanism of cationic peptide antibiotic activity against colistin-resistant bacteria$626,415
R01 · FY2025 · AI · contact PI
Structural determinants of activity and mechanism of cationic peptide antibiotic activity against colistin-resistant bacteria$626,415
R01 · FY2024 · AI · contact PI
Structural determinants of activity and mechanism of cationic peptide antibiotic activity against colistin-resistant bacteria$653,885
R01 · FY2023 · AI · contact PI
Determinants and Mechanisms of Efficacy of Peptide Antibiotics as Novel Sepsis Therapy$364,459
R01 · FY2022 · GM · contact PI
Determinants and Mechanisms of Efficacy of Peptide Antibiotics as Novel Sepsis Therapy$349,844
R01 · FY2021 · GM · contact PI
Determinants and Mechanisms of Efficacy of Peptide Antibiotics as Novel Sepsis Therapy$359,820
R01 · FY2020 · GM · contact PI
Determinants and Mechanisms of Efficacy of Peptide Antibiotics as Novel Sepsis Therapy$366,451
R01 · FY2019 · GM · contact PI
Determinants and Mechanisms of Efficacy of Peptide Antibiotics as Novel Sepsis Therapy$249,903
R01 · FY2019 · GM · contact PI
Determinants and Mechanisms of Efficacy of Peptide Antibiotics as Novel Sepsis Therapy$388,268
R01 · FY2018 · GM · contact PI